Skip to content

SiriusPoint SPNT Other Specialties — Year 6

Other product segments

Casualty
8.9%-88.5%
Property Catastrophe
3.7%0.0%
Property Other
2%-28.6%
Other
1%-9.1%
A&H
0%-100%

Similar metrics at other companies

Arch Capital Group logo
ACGLSpecialty — Year Six
3.8%-0.2pp
Arch Capital Group logo
ACGLMulti-line and other specialty — Year Six
3.7%+0.4pp
Arch Capital Group logo
ACGLSpecialty — Year Seven
1.2%-0.4pp
Radian Group logo
RDNSpecialty Segment Operating — Other Income
$1.33M
Markel logo
MKLOther products — Earned premiums
$64.62M+1.7%
CNA Financial logo
CNASpecialty — Other revenues
$1M0.0%

Other financials

Income statement

See full
Revenue$774.6M+6.5%
Net income$102.2M+65.9%
EPS (diluted)$0.82+67.3%

Balance sheet

See full
Cash & equivalents$1.0B+9.2%
Total debt$702.9M+2.2%
Total equity$2.3B+13.7%
Total assets$12.5B+1.6%

Cash flow

See full
Operating cash flow$141.9M+260%

Valuation

See full
Market cap$2.76B+25.6%

Profitability

See full
Net margin15.4%+8.4pp

Returns & leverage

See full
Return on equity23.1%+15.2pp
Debt / equity0.3×0.0×

Where this comes from

Reported directly by SiriusPoint in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix.

The official record: SiriusPoint’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about SiriusPoint's other specialties — year 6.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SiriusPoint's other specialties — year 6?
SiriusPoint (SPNT) reported other specialties — year 6 of 1.4% in Q4 2025.
What does other specialties — year 6 mean?
This metric measures the financial output of the Other Specialties segment during the sixth year, highlighting the segment's role in the company's broader underwriting strategy. It provides insight into how specialized risk products contribute to total premium volume and revenue diversification. Monitoring this helps determine the effectiveness of the company's product development and market positioning.